ETIRARX, INC.

Profile

Company Names

ETIRARX, INC.

Addresses

3060 PEGASUS PARK DRIVE, BUILDING 6, DALLAS, TX 75247

3060 PEGASUS PARK DRIVE, BUILDING B, DALLAS, TX 75247

3033 IRVING BLVD., DALLAS, TX 75247

Phone Numbers

469-600-6603

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$9,497,660.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2026-04-17 
$2,277,533.00 
$3,000,003.00 
$722,470.00 
Equity 
2
2025-06-06 
$2,399,987.00 
$4,869,987.00 
$2,470,000.00 
Equity 
1
2023-09-15 
$4,820,140.00 
$10,595,149.00 
$5,775,009.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RUSSELL 
 
HAYWARD 
EXECUTIVE OFFICER, DIRECTOR
WORLDEYE TECHNOLOGIES, INC.   |  ETIRARX, INC.
ANNALISA 
 
JENKINS 
DIRECTOR
PROSENSA HOLDING N.V.   |  BIOTHERA HOLDING CORP.   |  DIMENSION THERAPEUTICS, INC.   |  ARDELYX, INC.   |  ONCOSEC MEDICAL INC   |  VIUM, INC.   |  AGEX THERAPEUTICS, INC.   |  COCOON BIOTECH INC.   |  SKYE BIOSCIENCE, INC.   |  ETIRARX, INC.
GANESH 
 
RAJ 
EXECUTIVE OFFICER, DIRECTOR
ETIRARX, INC.
JUSTIN 
 
STEBBING 
DIRECTOR
CUREMARK LLC   |  ETIRARX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-04-17 
2025-06-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-06-06 
2023-10-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#